Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000847
Filing Date
2024-11-20
Accepted
2024-11-20 16:12:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 7069
  Complete submission text file 0001969223-24-000847.txt   8802
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39532 | Film No.: 241480507
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 35 WILSHIRE ROAD GREENWICH CT 06831
Business Address 35 WILSHIRE ROAD GREENWICH CT 06831 917-882-3618
Ayabudge LLC (Reporting) CIK: 0001878024 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144